Cargando…
Mitochondria-Targeted Mesoporous Organic Silica Nanoplatforms for Overcoming Cisplatin Resistance by Disturbing Mitochondrial Redox Homeostasis
Cisplatin (also known as DDP) resistance is one of the biggest challenges in the treatment of ovarian cancer. Recent studies have found that mitochondrion, as a potential target of DDP, participates in drug-related apoptosis and resistance. Overexpressed glutathione (GSH) in resistant cells is invol...
Autores principales: | Lv, Bin, Ma, Jingru, Wang, Yumeng, Qu, Xinyu, Qiu, Junjun, Hua, Keqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124779/ https://www.ncbi.nlm.nih.gov/pubmed/35615309 http://dx.doi.org/10.3389/fchem.2022.875818 |
Ejemplares similares
-
Indocyanine Green Loaded Modified Mesoporous Silica Nanoparticles as an Effective Photothermal Nanoplatform
por: Wang, Yiyu, et al.
Publicado: (2020) -
Mesoporous silica-based nanoplatforms for the delivery of photodynamic therapy agents
por: Hong, Suk ho, et al.
Publicado: (2017) -
Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders
por: Sivamaruthi, Bhagavathi Sundaram, et al.
Publicado: (2023) -
Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations
por: Djayanti, Krismala, et al.
Publicado: (2023) -
Nanoplatforms for Irinotecan Delivery Based on Mesoporous Silica Modified with a Natural Polysaccharide
por: Brezoiu, Ana-Maria, et al.
Publicado: (2022)